Sources :
– The Maudsley Prescribing Guidelines in Psychiatry 14th Edition (2021)
– The Stahl Prescriber’s Guide 8th Edition (2024)
– Leucht S, etc. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013 Sep 14;382(9896):951-62. doi: 10.1016/S0140-6736(13)60733-3.
– Huhn M, etc. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episodeschizophrenia: a systematic review and network meta-analysis. Lancet. 2019 Sep 14;394(10202):939-951. doi: 10.1016/S0140-6736(19)31135-3.
– Briet J, Javelot H, Heitzmann E, Weiner L, Lameira C, D’Athis P, Corneloup M, Vailleau JL. The anticholinergic impregnation scale: Towards the elaboration of a scale adapted to prescriptions in French psychiatric settings. Therapie. 2017 Sep;72(4):427-437.
– Owens DC. Meet the relatives: a reintroduction to the clinical pharmacology of ‘typical’ antipsychotics (Part 1). Advances in Psychiatric Treatment. 2012;18(5):323-336. doi:10.1192/apt.bp.109.006908
– Owens DC. Meet the relatives: a reintroduction to the clinical pharmacology of ‘typical’ antipsychotics (Part 2). Advances in Psychiatric Treatment. 2012;18(5):337-350. doi:10.1192/apt.bp.111.008920



SEP ?
symptômes extra-pyramidaux
Bonjour,
S’agissent ils de fréquences ou intensités d’EI ?
Merci
Les deux